Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital Read more
Atea Pharmaceuticals Introduces New Strategic Clinical Development Program for AT-527 in COVID-19 Read more
Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death Read more
Biogen and TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience Read more
Merck Collaborates with Innovative Biotech to Support Establishment of First Vaccine Production Facility in Nigeria Read more
Antengene Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate ATG-017 in Combination with Opdivo(nivolumab) in Advanced Solid Tumors Read more
AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders Read more
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control Platform Read more
Exclusive Speaker Interview with Martin Akerman, Envisagenics Released ahead of the RNA Therapeutics Conference 2022 Read more